1
/
of
1
ELK Biotechnology
SKU:ELK8044
General 8-epi-PGF2a(8-Epi Prostaglandin F2 Alpha) ELISA Kit
General 8-epi-PGF2a(8-Epi Prostaglandin F2 Alpha) ELISA Kit
Regular price
$376.00 USD
Regular price
Sale price
$376.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
General 8-epi-PGF2a(8-Epi Prostaglandin F2 Alpha) ELISA Kit
Overview
| Product name: | 8-epi-PGF2a(8-Epi Prostaglandin F2 Alpha) ELISA Kit |
| Reactivity: | General |
| Alternative Names: | 8-EpiPGF2-α; 8epi-PGF2a |
| Assay Type: | Competitive Inhibition |
| Sensitivity: | 9.55 pg/mL |
| Standard: | 2000 pg/mL |
| Detection Range: | 31.25-2000 pg/mL |
| Sample Type: | serum, plasma and other biological fluids |
| Assay Length: | 2h |
| Research Area: | Endocrinology;Pulmonology;Hepatology;Hormone metabolism; |
| Test principle: | This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with 8-epi-PGF2a protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to 8-epi-PGF2a. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of 8-epi-PGF2a in the samples is then determined by comparing the OD of the samples to the standard curve. |
Standard curve
| Concentration (ng/mL) | OD | Corrected OD |
|---|---|---|
| 2000.00 | 0.191 | — |
| 1000.00 | 0.310 | — |
| 500.00 | 0.567 | — |
| 250.00 | 0.895 | — |
| 125.00 | 1.169 | — |
| 62.50 | 1.537 | — |
| 31.25 | 1.869 | — |
| 0.00 | 2.028 | — |

Precision
Intra-assay Precision (Precision within an assay):CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays):CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
Recovery
Matrices listed below were spiked with certain level of recombinant 8-epi-PGF2a and the recovery rates were calculated by comparing the measured value to the expected amount of 8-epi-PGF2a in samples.
| Matrix | Recovery range | Average |
|---|---|---|
| serum(n=5) | 81-95% | 88% |
| EDTA plasma(n=5) | 87-99% | 93% |
| Heparin plasma(n=5) | 87-99% | 88% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of 8-epi-PGF2a and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
|---|---|---|---|---|
| serum(n=5) | 95-104% | 93-102% | 87-98% | 91-102% |
| EDTA plasma(n=5) | 88-97% | 86-97% | 85-103% | 89-97% |
| Heparin plasma(n=5) | 92-103% | 83-94% | 92-105% | 89-97% |
Share
